Genetic testing, via germline and somatic testing, is crucial in breast cancer to understand inherited risks and tumor ...

ReShape Lifesciences saw a surge in retail discussion as traders speculated on the potential approval of its proposed reverse ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Laekna (2105.HK) announced that the U.S. Food and Drug Administration (FDA) has approved the IND for LAE120, an internally discovered USP1 inhibitor, for the treatment of advanced solid tumors. LAE120 ...

Term life insurance is usually the simplest and cheapest policy you can buy. That's because it's only in force for a set period — generally between 10 and 30 years — and it doesn't have a cash ...

All humans have the BRCA genes (BRCA1 and BRCA2). You inherit one from each of your parents, and if one parent has a mutation ...

Eikon has now secured about $1.1 billion in venture dollars since its inception in 2019. Also in Eikon’s arsenal are two PARP inhibitors. One is meant to be more selective than similar, existing ...

February 28, 2025 Globe Life initially claimed few people were impacted by a June 2024 data breach. Globe Life hit with a pair of lawsuits over handling of 2024 data breach Globe Life, Inc. faces ...

If confirmed in further studies, the findings suggest that it may be time to reassess current treatment with PARP (poly(ADP-ribose) polymerase) inhibitor drugs, which block the ability of cells ...

And you are more likely to respond to a type of targeted drug called a PARP inhibitor. PARP is a protein found in our cells, it stands for poly-ADP ribose polymerase. It helps damaged cells to repair ...